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Evaluation of protection efficiency of different vaccination
programs against velogenic Newcastle disease virus in broiler
chickens: Comparative in field and in laboratory studies

Serageldeen Sultan1* Marwa Hamed2 Nabila Osman3*

Abstract
This study was conducted to evaluate the protective efficiency of different vaccines and vaccination programs
against Newcastle disease virus (NDV) in chickens, in the field and the laboratory. In the field, three commercial chicken
farms (LA, LB, and QC) used different types of live vaccines and vaccination programs via drinking water (DW) were
serologically estimated by hemagglutination inhibition (HI) assay to detect the level of circulating antibodies against
NDV. The laboratory study was carried out to assess whether the types of vaccine and their route of administration
influence the HI level and viral shedding. Chicken groups (G1-G5) except for the control were challenged with
velogenic NDV genotype VIIj circulating among vaccinated chickens in Egypt. The protection efficiency was evaluated
by HI test pre-and post-challenge, and the virus shedding post-challenge was quantitated by real-time RT-PCR. The
results of the field study indicated that although LA and QC farms showed clinical signs accompanied with high
mortality after the 2nd (HI=22.1) and 3rd (HI=23.2) vaccination doses, respectively, and velogenic NDV destroyed chickens
in these farms, the LB farm showed no deaths with apparently healthy birds (HI=2 3.3). In the laboratory inactivated and
alternative vaccinations have the highest protection HI titer with no virus shedding while live vaccination either in DW
or eye drops showed low protection and the virus was detected in chickens from the DW live vaccinated group. In
conclusion, the currently used in field vaccination programs and their routes of administration should be reconsidered
to combat NDV infection.
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Introduction
Newcastle disease (ND) represents a seriously
hazardous disease to poultry investments worldwide
because of its high morbidity and mortality rates (up to
100%) among infected birds, impaired body weight
gain and decreased egg production (Alexander 1997;
Alexander et al., 2012; Hines and Miller 2012). ND is
caused by the ND virus (NDV) or avian paramyxovirus1 which was recently reclassified as avian
orthoavulavirus-1 (AOAV-1), Avulovirinae sub-family,
Paramyxoviridae family in the order Mononegvirales
(ICTV 2019). Several genotypes of NDV have been
distributed among domesticated and wild birds and
genotype VIIj is the most predominant among the
vaccinated chickens (Radwan et al., 2013; Abdel-Glil et
al., 2014; Hassan et al., 2016; Fuller et al., 2017).
Over the last few decades serious outbreaks have
been reported among vaccinated chickens all over the
world (Kapczynski and King 2005; Fuller et al. 2017). In
Egypt, despite the application of routine prophylactic
measurements via intensive vaccine programs, where
the ND is endemic, ND outbreaks frequently occur
(Radwan et al., 2013; Abdel-Glil et al., 2014; Nabila et al.,
2014; Hassan et al., 2016). The question arises as to why
a massive vaccination program cannot protect chickens
against NDV infection and why the current vaccination
regimes do not effectively prevent the clinical disease
and virus shedding.
The factors that may impair antibody responses are
the immune status of the bird, environmental
conditions of the farm and the level of maternal
Table 1

immunity (Wajid et al., 2018). In addition to these, the
failure of the existing vaccine strains to produce
protective antibodies due to the genetic divergence
between the circulating strain and the vaccine strain
and the possibility of lower virus titer in live vaccines
due to heat instability (Yi et al. 2011), retarded
biosecurity and vaccination strategy and their routes of
administration (Martinez et al., 2018). Vaccination is
still the most effective method to combat ND
distribution among chickens.
The current research study was conducted to
compare the protective efficiency of the applied
vaccines and the vaccination strategies under field and
experimental conditions. Also, to elucidate the possible
factors that may affect the vaccination protection for
chickens against NDV.

Materials and Methods
The field study: Three commercial broiler farms located
in Luxor and Qena governorates (designated as LA,
LB, and QC) were investigated for the immunological
status of the vaccinated chickens against NDV. The
farm information included location, capacity, bird
strain, type of vaccine used, schedules and routes of
vaccination are shown in Table (1). The representative
serum samples (n=50) were collected from each farm
based on the schedules of vaccine administration and
the HI titer was determined against the NDV La Sota
strain antigen according to OIE (2018). The reference
antiserum for NDV (GD lab., Holland) was used as a
positive control for the HI test.

Data from the vaccinated broiler chicken farms

Farm name a
Farm capacity
Bird strain
Type of flock
Type of vaccine

Schedule of vaccines b

LA

LB

QC

5000
Sasso
Broiler

4000
Balady
Broiler

5000
Sasso
Broiler

Live
8th
(Hitchiner B1)
19th
(La Sota N-79)
29th
(La Sota) c

Live
7th
(La Sota)
17th
(La Sota)
27th
(La Sota)

-

-

Live
7th
(Hitchiner B1)
19th
(La Sota)
29th
(La Sota)
33rd
(La Sota)
DW
Qena

DW d
Administration route
Location
Luxor
a LA and LB stand for Luxor farms A and B; QC stands for Qena farm C
b Serum samples were collected before vaccine administration
c Not applied outbreak increased with mortality rate from 10% -30%.
d DW = drinking water

The laboratory study
The birds: Before purchasing the chicks for the
experimental study, poultry houses were cleaned and
disinfected by adopting standard disinfection
protocols. A total of 180 one-day-old broiler chicks
(Sasso-hybrid) were purchased from known sources
(Ahem Ghnnnam Breeder Company) and random
cloacal swabs and droplets were collected for
examination for NDV, and avian influenza virus (AIV)
before starting the study. Later on, the chicks were
grouped randomly into 6 groups (G). G1-G4 received
different vaccination programs against ND (Sultan et

DW
Luxor

al. 2016; Hassan et al. 2019), while G5 and the control
(G6) were unvaccinated groups, as shown in Table (2).
All bird groups were kept isolated and strict
biosecurity measures were provided. The groups were
littering reared and supplied with feed and water adlibitun during the experiment. The study lasted for a
period of seven weeks.
Challenged virus and Vaccines: The challenged NDV
(EG/CK/NDV/Luxor/2012) was isolated in 2012
from an outbreak in a vaccinated broiler farm in Luxor,
Egypt, and the nucleotide sequences of F and HN
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genes were registered in GenBank under the accession
numbers MN381174 and MN381175, respectively. The
virus was propagated and titrated in 9-11 day old
embryonating chicken eggs that were free from
maternal antibodies against ND and stored at -70°C
until
use.
The
virus
challenge
dose
(105EID50/0.2ml/bird) was calculated based on the
method described by Reed and Muench (1938). All
vaccinated groups as well as G5 were challenged by the
EG/CK/NDV/Luxor/2012 via ocular and oral routes
at a dose of 0.1 mL/route.

Chicken
groups a

The different NDV live vaccines used in field farms
are illustrated in Table (1). Also, different live and
inactivated NDV vaccines used throughout the
experiment were purchased from local dispensers
Table (2) and supplementary table (S1) contain all
vaccines details (name, type, batch no., titer, dose,
route, manufacturer). The vaccines were stored and
diluted according to the manufactures’ instructions.
Live vaccines were administered via drinking water
(DW) or eye drop instillation, while the inactivated
vaccines were administered via intramuscular
injection in the breast muscle.

Time course of the experimental vaccination study
Vaccination timetable
7th

10th

17th

Program type

28th

G1
La Sota N-63
Clone 30
(La Sota N-79)
Alternative
(n=40)
(Live)
(Inactivated)
(Live)
vaccination
G2
La Sota N-63
Clone 30
La Sota
Ulster
Inactivated
(n=40)
(Live)
(inactivated)
(inactivated)
(inactivated)
vaccination
G3
La Sota N-63
Clone 30
(La Sota N-79)
Live (eye drop)
(n=30)
(Live)
(Live)
(Live)
vaccination
G4
La Sota N-63
Clone 30
(La Sota N-79)
Live (DW)b
(n=30)
(Live)
(Live)
(Live)
vaccination
G5
Non-vaccinated chicks
(n=20)
(control positive)
G6
Non-vaccinated non challenged chicks
(n=20)
(control negative)
a Live vaccines via eye drop in G1-G3 and inactivated vaccine via intramuscular injection.
b DW = drinking water
Table S1
Name

Virus challenge
35th

Chickens were
challenged by velogenic
NDV VIIj
(EG/CK/NDV/Luxor/
168/2012)

Table 2
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Supplementary table showing details of vaccines used in the laboratory study
Type

La Sota N-63
live
La Sota N-79
live
Clone 30
live
La Sota (OL-VAC)
inactivated
Ulster
inactivated
Clone 30
inactivated
a EID50 = egg infectious dose 50
b PD50 = protection dose 50
c DW = drinking water
d I/M = intramuscular

Batch no.

Titer

Dose

Route

manufacturer

94020045
94040053
0568H
311972
400594
1332301

106.5 EID50a
106.5 EID50
106 EID50
100 PD50b
50 PD50
30≥50 PD50

1000 dose
1000 dose
1000 dose
0.5 ml/bird
0.3 ml/bird
0.1 ml/bird

DWc or eye drop
DW or eye drop
DW or eye drop
I/Md
I/M
I/M

Intervet Inc., (MSD) USA
Intervet Inc., (MSD) USA
Izovac, Bresqa-Italy
Fatro, Ozzano Emilia (BO) Italy
Merial Lyon-France
Intervet Inc. Boxmeer-Holland

Serum sample collection for the HI assay:
Representative serum samples (n=10) were obtained
from birds in each group before vaccination at 1 and 7
days old to assess the maternal antibody level by HI
assay (OIE 2018). After that, the scheduled timetable
was followed to collect serum samples (n=7) from each
group weekly until 35 days old before performing the
challenge test. Then sera were collected daily postchallenge for the period of a week.
Clinical signs, postmortem lesions and mortality rate:
The mortality rate and clinical signs post-challenge
were recorded daily and dead birds were subjected to
postmortem examination.
Virus shedding estimation by real time reverse
transcription polymerase chain reaction (real-time
RT-PCR): Cloacal swabs (n=8 swabs) from randomly
selected birds in each group were collected daily postchallenge from 36 to 42 days old, 8 and 14 days from
last vaccination, for detection and quantification of
viral shedding by real time RT-PCR method as

previously described by Wise et al., (2004) for the
identification of virulent NDVs. The swabs were
collected in 1.5 ml sterile Eppendorf tubes containing
phosphate buffer saline (PBS) and antibiotics and
centrifuged at 5000xg / 15mins for virus clarification
and the supernatant was stored at – 80°C until
subsequent analysis. The RNA was extracted from the
samples using a QIAamp viral RNA Min (Qiagen,
USA) extraction kit following the manufacturer’s
instructions. Real-time RT-PCR process was performed
using QuantiTect® Probe RT-PCR kit (Qiagen, USA),
primers (Forward 5’-TCCGGAGGATACAAGGGTCT3’, Reverse 5’-AGCTGTTGCAACCCCAAG-3’), and
probe
([FAM]AAGCGTTTCTGTCTCCTTCCTCCA[TAMRA]) targeting 101 bp of the F gene (Wise
et al., 2004). Briefly, the reaction mixture volume was a
total of 25µl in a 0.2 ml optical tube (Applied
Biosystem) containing the following: 12.5µl master
mix, 0.5µl forward primer, 0.5µl reverse primer, 0.125
µl probe, 0.125 µl QuantiTect RT mix, 4.25 µl RNase free
water, and 7 µl of extracted RNA template. The
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reaction was conducted using a real-time RT-PCR
machine (Stratagene MX3005P) with a thermal profile
of RT at 50°C/30 mins for one cycle, initial
denaturation at 95°C/5mins for one cycle, and 40
cycles of denaturation (95°C/20secs), annealing
(52°C/30secs), and extension (72°C/10 secs).
Statistical analysis: The HI titers were expressed as
the geometric means of the evaluated serum samples
with geometric standard deviations. The variances
among the chicken groups were analyzed by two-way
ANOVA with Tukey’s multiple comparisons test in
Graph-Pad Prism version 8.4.2. A P value < 0.05 was
considered statistically significant (*P < 0.05, **P < 0.01,
and ***P < 0.001) and, a P value > 0.05 indicated no
significant (ns) difference.
Ethical approval: All experiment procedures carried
out on chickens were approved by the Ethics
Committee of the Faculty of Veterinary Medicine,
South Valley University, Qena, Egypt and care was
taken to minimize the number of animals used. All
serum samples were collected from farms carried out
after the advance agreement of the owners.

Results
Immune response of vaccinated broiler chicken farms
(field study): The geometric means of the HI titers of
the vaccinated broiler chickens in the 3 evaluated farms
were plotted as shown in Fig. (1). In the LA commercial

Figure 1

farm, the HI titer was 25.8 at one-day-old and then
dropped to 22.1 after the 1st vaccination and slightly
increased to 23.2 after the 2nd vaccination dose. After the
3rd vaccination, a few birds died with unclear PM
lesions and then the mortality speedily increased to
reach up to 80% of the flock (Fig. (1) and Table (1)). The
collected cloacal swabs from the chickens after obvious
mortality revealed NDV infection with Ct value 31.85
using real-time RT-PCR.
In the LB commercial farm, the sera collected from
the chickens at one-day-old, 16, 26, and 40 days old
showed 24.6, 22.1, 23.2, and 23.3 antibody titers against
NDV before and after vaccination (Fig. (1) and Table
(1)). On the other hand, in the QC farm the maternal
antibodies were 28.2 at 7 days old, 12 days after the 1 st
vaccination dose with Hitchiner B1, it decreased to 23
and to 22.1 a week after administration of 2 nd La Sota
vaccine dose (Fig. (1) and Table (1)). No serum samples
could be obtained after the 3 rd dose due to the farm’s
biosecurity measurements. Interestingly, the HI titer
speedily increased 5 days after the 4 th vaccination dose
up to 29.9 (Fig. (1)) and inconsistent with that increased
mortality started to destroy up to 85% of chickens with
the classical clinical signs (greenish diarrhea, off food,
nervous manifestations, facial edema) and PM lesions
(petechial hemorrhage on proventriculus, hemorrhage
in cecal tonsils, intestinal ulceration) of ND, and
confirmed isolation and identification of the velogenic
NDV were done from the tissue samples that were
collected at PM examination from the dead birds by
real time RT-PCR.

The calculated geometric mean of the HI titers for vaccinated broiler chickens using live vaccines via DW in the
investigated farms in Luxor (LA, and LB) and in Qena (QC) shown at one day old (maternal antibodies) and after each
vaccine administration. The vaccinated chickens in the LA and QC farms revealed increased mortalities after the 2 nd and
3rd vaccination doses, respectively. The protection level (≥ 3log2) is shown as a horizontal line.
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Assessment of HI titers of chicken groups (in
laboratory) receiving different vaccination programs:
The result of antibody titers in different groups are
presented in fig (2). The HI antibody titers in all
vaccinated groups were highly significant (P < 0.0001)
in comparison to the control group, except for at 1 and
7 days old (Fig. 3).
By the 17th day, the highest HI geometric mean of
antibody titer was observed in G2, followed by G4,
while G5 and the control showed the lowest antibody
titers. At 28 days old, vaccinated G1 showed the
highest antibody titers among different groups as well
and the titer level of this group being increased
compared to those levels at 17 days old reflecting a
higher protection level than G3 and G4 vaccinated with
live vaccine only. While in G5 and the control group
the antibody titers decreased in comparison to those
determined at 17 days old and completely diminished
at 28 days old.
G2, receiving inactivated vaccines, a week post last
vaccination dose (35 days old), had a highly significant
HI titer (P < 0.0001) in comparison to other vaccinated
groups. Both G2 and G1 showed nearly double the HI
titer of G3 and G4 at this period (Fig. (2) and (3)).
Interestingly, G3 showed a highly significant HI
titer (P < 0.0001) in comparison to G4, although they

Figure 2
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received the same vaccines but with different
administration routes (Fig. (2) and Table (2)).It is worth
noting that G1 showed a marked drop in the HI titer 4
days post challenge (dpc) to reach the same level as G3
(Fig. (3)).
The chickens receiving inactivated vaccines (G2)
showed a steady HI titer curve, although it was slightly
decreased 3 dpc (38 days old). In contrast, the birds that
received live vaccines via DW (G4) showed a sudden
transient increase in HI titer at the same time period.
Also, this group showed a steady increase in HI titer 4
- 7 dpc to overtake birds receiving the same vaccination
program via eye drops (G3), (Fig. (3) and Table (2)).
Surprisingly, the HI titers of G3 and G4 remained
under the level (≤ 4log2) even post-challenge (6 days
post challenge for G3), as shown in Fig. (3).
The challenged non-vaccinated birds (G5) showed
a prompt increase in the HI titer 3 dpc (Fig. 3), which
was accompanied by increased disease severity and
fatality. In contrast to this, the non-challenged nonvaccinated chickens (the control group) remained in a
sound condition with no HI titer since maternal
antibodies had been diminished at 28 days old till the
end of the experiment.

The graph shows the statistical relationship among the chicken groups: G1 (alternative vaccines), G2 (inactivated
vaccines), G3 (live vaccines via eye drop), G4 (live vaccine via DW), before and after vaccination and daily post-virus
challenge. The G5 non-vaccinated, challenged chickens and the control group (non-vaccinated, non-challenged chickens)
regarding HI titers and timing by two-way ANOVA with Tukey’s multiple comparisons test in Graph-Pad Prism version
8.4.2. The groups were highly significantly (a, b, c, d and e) different (P ≤ 0.0001) from 17 days old until the end of the
experimental period.
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Figure 3

Monitoring of the geometric mean of the HI titers among the chicken groups (G1-G5 and the control): G1 (alternative
vaccines), G2 (inactivated vaccines), G3 (live vaccines via eye drop), G4 (live vaccine via DW), before and after vaccination,
and daily post-virus challenge. The G5 non-vaccinated, challenged chickens and the control (non-vaccinated, nonchallenged chickens) group. The protection level (≥ 3log2) is shown as a horizontal line.

Molecular evaluation of the virus shedding after virus
challenge in different groups: The investigation of virus
shedding among the vaccinated chicken groups as well
as G5 and the control groups was conducted by realtime RT-PCR. All examined cloacal swabs collected
from the chicken groups daily after virus challenge
showed no viral shedding for G1, G2 and G3 as well as
the control group up to 7 dpc (Table (3)). On the other
hand, in G5 after detecting HI antibody titer, 3dpc, the
Ct values were detected, 4dpc (Fig. (3) and Table (3))
where the classical clinical signs and mortality were
recorded among birds in this group. Later on, the Ct
Table 3

values decreased, indicating a high virus load
congruent with the increased severity of clinical signs,
mortalities and HI titers (Fig. (3), Table (3)). By 7 dpc,
almost all the birds had died in G5 with a mortality rate
of 90%, only two birds were alive up to 14 dpc with
classical clinical signs of NDV, after that they were
euthanized where PM lesions of NDV were obvious.
Interestingly, the Ct values of 27.27 and 29.7 from an
individual bird in G4, receiving live vaccine via DW,
were recognized at 6 and 7 dpc with HI titers of 2 4.6
and 25.3, respectively, (Table (3), Fig. (3)).

Real-time RT-PCR results of the shedding virus from obtained samples from various bird groups at 1 -7 days postchallenge (dpc).
Positive samples/examined samples (Ct value)

Groups

1dpc

2dpc

3dpc

4dpc

5dpc

6dpc

7dpc

G1
G2
G3

0/8
0/8
0/8

0/8
0/8
0/8

0/8
0/8
0/8

0/8
0/8
0/8

0/8
0/8
0/8

G4

0/8

0/8

0/8

0/8

0/8

G5

0/8

0/8

0/8

8/8
(32.03)
0/8

8/8
(30.62)
0/8

0/8
0/8
0/8
1/8
(27.72) b
8/8
(31.69)
0/8

0/8
0/8
0/8
1/8
(29.07)
8/8
(28.17)
0/8

Control
0/8
0/8
0/8
ND means not detected
b the cycle threshold (Ct) value of real time RT-PCR shown in brackets

Virus shedding
ND a
ND
ND
Virus detected
Virus detected
ND

a

Discussion
The ND economic losses and costs related to
preventive measurements raise the need for evaluating
the type of vaccines and the efficacy of vaccination
programs used in controlling NDV in Egypt.
Therefore, the question arises whether the currently
used vaccines under different vaccination schemes in
field induce effective immunity in chickens against the
virulent NDV, which reflects back into mortality rates,
clinical signs, postmortem lesions, level of antibody
titer and viral shedding.

In this study, 2 (LA and QC) out of the 3 broiler
chicken farms that used live vaccination programs
through DW had ND outbreaks, which has been
confirmed by molecular and biological identification
methods. Also, the level of HI titer reached up to 2 9.9 in
the QC farm, which contributed to viral infection.
Conversely, to the LA farm, all chickens passed to the
market in the LB with HI titer, after the 2 nd and 3rd
vaccination doses (23.2 and 23.3, respectively) similar to
HI titer (23.2) of chickens in LA farm. Although the 2
broiler chicken farms, LA and LB, on follow-up, had
optimal protection levels of HI titer 2 3.2 and, 23.3,
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respectively, (Sultan et al., 2016), ND outbreaks
occurred in LA only, which may be attributed to the
presence of immunosuppressive (Njagi et al., 2012)
factors such as co-infection with other pathogens as
AIV H9N2, infectious bronchitis virus (IBV), infectious
bursal disease virus (IBDV), fowl adenovirus (FAdV),
chicken
anemia
virus
(CAV),
infectious
laryngotracheitis virus (ILTV), Escherichia coli or
Mycoplasma (Hassan et al., 2016; Sultan et al., 2016;
Gowthaman et al., 2017; Gowthaman et al., 2019). In
addition to this, the genetic resistance of local chicken
breeds plays a role in minimizing and resisting the
infection by NDV with or without improving the
humoral immune response (Hassan et al., 2004; ElTarabany 2019). This is congruent with the results that
although LA and LB farm chickens had the same HI
titers but of different bird breeds, only LB farm
chickens could remain apparently healthy without
NDV mortality. The outbreak occurring in the QC farm
has been attributed to sub-optimal HI titer (22.1). The
results revealed that commercial attenuated live ND
vaccine, especially in DW, cannot provide satisfactory
protection against NDV and this agrees with Yu et al.,
(2012). This result is in agreement with Van-Boven et
al., (2008) and Ashraf and Shah (2014), who revealed
that the in-field outbreaks of ND and the re-infection
of susceptible birds with NDV have occurred in flocks
with lower immunity despite intensive vaccination
with various live vaccination schedules. In addition to
the immunosuppressive or co-infection agents such as
low pathogenic AIV H9N2 which has a detrimental
effect on the HI titer and exaggerates the clinical signs
in infected birds vaccinated with live NDV vaccines
(Ellakany et al., 2018), several individual birds showed
HI titer less than 21, which puts them at risk of NDV
infection due to inadequate neutralizing antibody titer.
Also, the laboratory study revealed that a live
vaccination program via DW did not fully protect the
chickens, as individual chickens were infected after
virus challenge and virus shedding was detected at 6
and 7 dpc by real time RT-PCR. This result is consistent
with previous studies that indicated that live vaccines
via DW did not provide sufficient protection to
chickens against NDV (Alexander et al., 2004; Degefa et
al., 2004). Meanwhile, infection could not be detected
in that group receiving the same live vaccination
program through eye drops, which could be because of
the specific local antibodies secreted by stimulated
plasma cells in the Hadrian gland (Dohms et al., 1988;
Jayawardane and Spradbrow 1995). The in-field and
laboratory studies revealed that the live vaccine
application via DW provided a poor HI titer. This is
due to the fact that to none of the birds took the
optimum amount of vaccine; live vaccines may be
affected by environmental conditions such as high
temperature in tropical regions, exposure time and the
water quality used for vaccine reconstitution, which
affects live vaccine viability and stability(Alexander et
al., 2004).
Therefore, the basic hypothesis of using different
vaccination regimes in the in laboratory study was that
the efficacy of live vaccines administered via DW
commonly used in the broiler farms in our country
could be improved by subsequent administration of
inactivated vaccines using different vaccination
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programs (inactivated and alternative). The commonly
used vaccines for controlling NDV based on the
lentogenic strains (La Sota, B1, Ulster) and the effective
dose of live vaccines (104 – 105 EID50) that conveys
100% protection under laboratory conditions do not
prevent challenge virus infection and replication.
However, La Sota derived vaccines of 10 6 EID50 or
higher induce efficient HI titer able to prevent or
strictly minimize the challenge virus replication
(Kapczynski and King 2005; Cornax et al., 2012;
Cardenas-Garcia et al., 2015). The high level of
maternal antibodies at the time of vaccination
adversely affects the protection derived from a
primary or booster vaccination against NDV(Martinez
et al., 2018). The maternal antibodies can impair the
vaccine efficiency though preventing vaccine strain
replication and immune response, inhibiting the B cell
differentiation into antibody producing plasma cells or
masking epitopes, neutralizing and enhancing
phagocytosis of virus particles enter blood stream (Hu
et al. 2020). So, the vaccination programs under
laboratory conditions were applied at 7 days old after
maternal antibodies had declined and all selected live
vaccines in this study were 106 EID50 or higher as
shown in table (S1).
The birds in all groups were primed with live ND
vaccine at 7 days old after the maternal antibody titer
dropped to avoid interference with the vaccine,
enhance instant protection as well and induce local
mucosal immunity (Martinez et al., 2018). The decline
in antibody titer recorded at 17 days of age in G1, G3,
and G4 (< 23) is explained by the live vaccine being
neutralized by remaining maternal antibodies. While
in G2, the antibody titer was steadily more stable
throughout the experimental course than others,
because of the use of inactivated NDV vaccine as a
primary or booster vaccination inducing efficient and
sustained immunity for a long time and not interfering
with maternal immunity as a live vaccine
(Chansiripornchai and Sasipreeyajan 2006).
G2 had the highest geometric mean of antibody
followed by G1; this indicates a better immune
response to NDV. A combination of live and
inactivated oil adjuvant ND vaccine is recommended
for endemic areas because vaccine combination is
known to promote a better immunological protection
than administration of only a single live vaccine
(Chansiripornchai and Sasipreeyajan 2006). This high
antibody response obtained with killed and live
vaccine given simultaneously is due to that the live
virus replicating quickly in the mucosal membrane of
the conjunctiva and nostrils and eliciting a primary
immune response. This is followed by a continuous
slow release of the killed virus antigen being trapped
in the oil medium, thus allowing the killed virus
antigen trapped to behave like a booster dose
(Chansiripornchai and Sasipreeyajan 2006; Folitse et al.,
1998).
By the end of the experiment (7 dpc) chickens in G1
and G2 using alternative and inactivated vaccinations
showed a geometric mean of HI titer > 2 6. While HI
titers for G3 and G4 received only live vaccine by eye
drops and DW, respectively, remained lower (≤ 2 2.5-4 in
G3 and G4). This finding is also in agreement with the
FAO (Alexander et al., 2004) notification which
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concluded that killed ND vaccine induced more
effective and long-term immunity than live ND vaccine
La Sota.
Concerning viral shedding, all groups were
protected against viral shedding except for G4, where
it occurred due to the homogenized high antibody titer
in G1, G2, and G3 that may have been responsible for
non-detectable virus shedding compared with G4.
Controversially, Sedeik et al., (2019) reported virus
shedding and clinical signs in all chicken groups
receiving heterologous or homologous inactivated
vaccine 2 and 3 weeks post-challenge with HI titer < 24
before challenging the vaccinated chicken groups. This
is due to the higher maternal antibody (27.9) at time of
vaccination and the lack of a booster vaccination dose.
The lowest HI titer permitted the virus to replicate and
shed within the fecal samples and the birds in this
group (G4) were not fully protected against infection
(Reynolds and Maraqa 2000; Jalil et al., 2009). Also, at
3dpc the HI titer was 24.7 in G4 and increased by up to
25.3 at 7dpc which can be counted towards the infection
of NDV which was confirmed by the detection of Ct
value of individual birds in this group by real-time RTPCR at 6 and 7 dpc.
In conclusion, the results of our study point out that
the commonly used vaccination programs in-field
should be reconsidered in both the type of vaccine and
the route of its application among commercial chicken
broiler farms. The use of alternative and inactivated
vaccine programs induces high HI titers with nondetectable viral shedding. The application of
alternative and inactivated vaccine programs in
endemic areas has the potential to provide not only
good protection but also to reduce dissemination of
virulent NDV. Therefore, it is necessary to pay great
attention to the types of vaccines, schedules of
vaccination and application processes to obtain an
efficient protection level for birds against NDV.
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